August 13th, 2009

Bone-preserving drug passes tests in men, women

By Kelley Luckstein

A new drug increases bone density and reduces the number of fractures in men fighting prostate cancer and in elderly women with bone loss, researchers report in two studies appearing August 11 in the New England Journal of Medicine… “This certainly goes a long way toward fulfilling the criteria the FDA uses,” says Sundeep Khosla, an endocrinologist at the Mayo Clinic in Rochester, Minn., who didn’t participate in these trials.

 

ScienceNews by Nathan Seppa, 8/11/2009

 

Additional coverage:

Health.com
Medline Plus
St. Petersburg Times

 

 

Tags: endocrinology, Endocrinology / Diabetes, osteoporosis, prostate cancer, Research

Contact Us · Privacy Policy